Not All Information Is Worth Asking For: Decision-Informed Information Seeking with LLMs
Organizations: LG AI Research
Abstract
Large language models (LLMs) are increasingly used to support decisions under incomplete information, where deciding what to look up and when to stop matters as much as the final answer. However, LLMs fall into an information trap: They pay for checks, i.e., costly pieces of evidence, that cannot change their decision or are not worth their cost, and they keep asking when the evidence is already sufficient. To this end, we propose Decision-Informed Value-of-information Acquisition (DIVA), a simple yet effective procedure for LLM information seeking based on the decision value of evidence. DIVA 1) lets the LLM specify a small decision model, i.e., how likely a bad outcome is and how each check would shift this probability, through short numeric questions and 2) values each candidate check by how much its imagined outcomes improve the decision net of its cost, stopping when no check is worth its cost. Its variant, DIVA-U, further accounts for the LLM's uncertain estimates of how strongly each check shifts this probability. DIVA is training-free and applies to any LLM. Across four domains and 20 LLMs, DIVA-U has lower regret, i.e., value lost relative to the best possible decision, than every LLM baseline on real-world data, mainly by stopping once evidence suffices, and DIVA cuts the regret of the best LLM baseline by 75% in synthetic scenarios where every check's reliability is given. Code: github.com/seunghan96/diva.
Figures & tables
| [1] Which information to acquire? | [2] When to stop? | Training-free | ||
| Decision value | Elicited model | Stopping rule | ||
| Information seeking with LLMs | ||||
| FinRiskAtlas ( Zhong et al., 2026 ) | – | – | Ask-or-proceed | ✓ |
| QuestBench ( Li et al., 2025a ) | – | – | – | ✓ |
| MediQ ( Li et al., 2024 ) | – | – | Abstention | ✓ |
| Information gain | ||||
| Action | (Benign) | (Adverse) |
|---|---|---|
| act | ||
| pass |
| Method (Avg. across 20 LLMs) | Knowledge-required environments | Controlled environments | ||||||||||
| Credit | Clinical | SEC filings (2025–2026) | Finance | Credit | Clinical | Legal | ||||||
| Taiwan | German | CDC | Heart | Ret-1d | Ret-5d | Vol-5d | Vol-20d | |||||
| Prompting | ||||||||||||
| Direct | 6.47 | 5.15 | 5.23 | 6.30 | 1.26 | 1.21 | 1.24 | 1.08 | 4.69 | 4.35 | 6.22 | 5.80 |
| CoT ( Wei et al., 2022 ) | 7.50 | 6.53 | 6.56 | 6.87 | 1.19 | 1.25 | 1.28 | 1.10 | 4.71 | 4.20 | 5.78 | 5.96 |
| SC ( Wang et al., 2023 ) | 7.52 | 6.67 | 6.82 | 6.81 | 1.17 | 1.26 | 1.27 | 1.03 | 4.42 | 4.17 | 5.84 | 5.64 |
| Method (Avg. across 20 LLMs) | Knowledge- required | Controlled |
|---|---|---|
| Prompting | ||
| Direct | 18.98 | 28.46 |
| CoT ( Wei et al., 2022 ) | 20.64 | 28.00 |
| SC ( Wang et al., 2023 ) | 22.87 | 29.84 |
| ReAct ( Yao et al., 2023 ) | 19.99 | 23.98 |
| Decision-aware prompting | ||
| Variant | Regret ( 100) | |
|---|---|---|
| Direct | 5.52 | – |
| + Decision value on imagined beliefs | 3.49 | 2.03 |
| + Elicited decision model (11-option) | 1.68 | 1.81 |
| + Numeric answers (= DIVA) | 0.83 | 0.85 |
| + DP lookahead (= DIVA-DP) | 0.48 | 0.35 |
| DIVA with cost-blind EIG | 5.03 | +4.20 |
| Method | DP regret | Episode regret | ||
|---|---|---|---|---|
| Know. | Ctrl. | Know. | Ctrl. | |
| VoI-Ask ( Dong et al., 2026 ) | 1.99 | 4.06 | 2.40 | 11.16 |
| DIVA | 1.29 | 2.09 | ||
| DIVA-U | 0.65 | 0.86 | 2.77 | 1.80 |
| DIVA-DP | 1.07 | 0.54 | 1.86 | 1.58 |
| Method | Check strengths | Knowledge-required | Controlled | |
|---|---|---|---|---|
| Records | SEC | |||
| Best LLM baseline | 1.49 | 1.10 | 4.04 | |
| Never | 1.31 | 3.12 | 4.67 | |
| DIVA | One shared | 0.72 | 1.23 | 2.07 |
| From LLM | 0.77 | 1.80 | 0.86 | |
| DIVA-U | One shared | 0.52 | 0.63 | 1.50 |
| Domain | Environment | Source | Decision | Checks | Test |
| [1] Knowledge-required environments | |||||
| Credit | Taiwan | Credit-card default ( Yeh and Lien, 2009 ) | Approve / decline | 6 (Binary) | 2,000 |
| German | German credit ( Hofmann, 1994 ) | Approve / decline | 6 (Binary) | 1,000 | |
| Clinical | CDC | CDC diabetes indicators ( Centers for Disease Control and Prevention, 2017 ) | Skip / refer | 6 (Binary) | 2,000 |
| Heart | UCI heart disease ( Janosi et al., 1989 ) | Skip / refer | 6 (Binary) | 1,000 | |
| SEC filings | Ret-1d, Ret-5d | S&P 500 SEC filings | Buy / pass | 6 (Terciles) | 3,437 / 3,433 |
Appendix figures & tables38 assets
Supplementary material from the paper’s appendix.
Appendix
| Parameter | Knowledge-required | Controlled | |
|---|---|---|---|
| Records (Taiwan, German, CDC, Heart) | SEC filings (Return and volatility targets) | ||
| Checks | 6, one uninformative in half of the scenarios | Up to 5 from the filing and 1 uninformative | 6 (10 or 12 in many-item scenarios), 1 uninformative |
| Known findings | 0, 1, or 2, with probabilities 0.4, 0.4, and 0.2 | ||
| Payoffs | , with within 0.08 of the reference belief | ||
| Cost regime | |||
| Cost factor | |||
| Term | Meaning |
|---|---|
| Episode | One decision case |
| State ( ) | The outcome of interest, unknown when deciding |
| Action, payoffs ( , , ) | The two actions, the gain of acting if benign, and the loss of acting if adverse |
| Check, outcome, cost ( , , ) | A piece of evidence that can be acquired, what it shows, and its price |
| Known findings ( ) | Outcomes already observed before deciding |
| Base rate ( ) | Probability of the adverse case before any finding |
| Family | Size | Hugging Face checkpoint | Precision | License |
| Qwen3 | 0.6B | Qwen/Qwen3-0.6B | BF16 | Apache-2.0 |
| 1.7B | Qwen/Qwen3-1.7B | BF16 | Apache-2.0 | |
| 4B | Qwen/Qwen3-4B | BF16 | Apache-2.0 | |
| 8B | Qwen/Qwen3-8B | FP8 | Apache-2.0 | |
| 14B | Qwen/Qwen3-14B | BF16 | Apache-2.0 | |
| 32B | Qwen/Qwen3-32B-AWQ | AWQ 4-bit | Apache-2.0 |
| Category | Method | How the first action is chosen |
| Prompting | Direct | The LLM answers with one option letter (A check or stop) without rationale, and the letter of highest probability, averaged over option orders, is taken. |
| CoT ( Wei et al., 2022 ) | The LLM reasons step by step about what it still needs, given the costs, and ends with “ANSWER: X” (Up to 1,024 tokens). | |
| SC ( Wang et al., 2023 ) | Majority vote over five CoT samples (One request, temperature 0.7). | |
| ReAct ( Yao et al., 2023 ) | The LLM writes one Thought and one Action, either check[X] or a final decision (Up to 512 tokens per step). | |
| Decision-aware prompting | Ask-P ( Zhong et al., 2026 ) | The LLM chooses between proceeding and asking for one more costly item, and if it asks with probability , it acquires the item it names (Averaged over three orders), else it stops. |
| VoI-P | The LLM states each check’s net value in JSON after brief reasoning, and the largest positive one is acquired. |
| Env. | Never | Always ask | DIVA- | DIVA- | DIVA | DIVA-U | Stop opt. | Stop DIVA | Stop DIVA-U | Stop VoI-Ask |
|---|---|---|---|---|---|---|---|---|---|---|
| Taiwan | 1.02 | 4.65 | 0.43 | 0.40 | 0.52 | 0.41 | 0.65 | 0.69 | 0.56 | 0.93 |
| German | 0.91 | 4.93 | 0.49 | 0.51 | 0.64 | 0.51 | 0.69 | 0.75 | 0.57 | 0.98 |
| CDC | 0.36 | 4.96 | 0.22 | 0.20 | 0.26 | 0.20 | 0.76 | 0.84 | 0.70 | 0.75 |
| Heart | 2.81 | 4.28 | 1.70 | 1.07 | 1.64 | 1.08 | 0.61 | 0.85 | 0.72 | 0.86 |
| Ret-1d | 2.69 | 0.68 | 0.92 | 0.61 | 0.95 | 0.64 | 0.34 | 0.32 | 0.01 | 0.65 |
| Ret-5d | 1.14 | 0.85 | 0.74 | 0.64 | 0.80 | 0.77 | 0.52 | 0.39 | 0.02 | 0.71 |
| Method (Avg. across 20 LLMs) | Knowledge-required environments | Controlled environments | ||||||||||
| Credit | Clinical | SEC filings (2025–2026) | Finance | Credit | Clinical | Legal | ||||||
| Taiwan | German | CDC | Heart | Ret-1d | Ret-5d | Vol-5d | Vol-20d | |||||
| Prompting | ||||||||||||
| Direct | 31.24 | 31.23 | 30.69 | 34.40 | 6.73 | 5.47 | 6.00 | 6.10 | 28.60 | 23.92 | 30.04 | 31.29 |
| CoT ( Wei et al., 2022 ) | 35.27 | 34.02 | 33.06 | 34.61 | 7.65 | 6.28 | 7.11 | 7.14 | 27.55 | 24.63 | 28.44 | 31.39 |
| SC ( Wang et al., 2023 ) | 39.55 | 38.40 | 37.29 | 37.44 | 8.22 | 6.95 | 7.67 | 7.45 | 29.11 | 25.75 | 31.29 | 33.20 |
| Method | Records | SEC filings | ||||||
|---|---|---|---|---|---|---|---|---|
| Taiwan | German | CDC | Heart | Ret-1d | Ret-5d | Vol-5d | Vol-20d | |
| Reference | ||||||||
| Never | 0.89 | 1.06 | 0.31 | 2.96 | 2.64 | 1.76 | 3.71 | 4.38 |
| Generic decision model (One strength for every check) | ||||||||
| Generic DIVA | 0.65 | 0.51 | 0.19 | 1.52 | 1.12 | 0.82 | 1.39 | 1.57 |
| Generic DIVA-U | 0.44 | 0.45 | 0.12 | 1.06 | 0.61 | 0.65 | 0.65 | 0.60 |
| Method | Taiwan | German | CDC | Heart |
|---|---|---|---|---|
| Reference | ||||
| Never | 1.02 | 0.91 | 0.36 | 2.81 |
| Threshold heur. | 1.02 | 0.91 | 0.38 | 3.07 |
| Supervised ref. | 0.05 | 0.11 | 0.04 | 0.29 |
| Shuffled likelihoods | ||||
| Knowledge-free DIVA | 0.64 | 0.61 | 0.28 | 1.71 |
| Variant (Avg. across 20 LLMs) | Credit | Clinical | SEC filings (2025–2026) | Avg. | |||||
|---|---|---|---|---|---|---|---|---|---|
| Taiwan | German | CDC | Heart | Ret-1d | Ret-5d | Vol-5d | Vol-20d | ||
| DIVA w/ EIG (Fixed threshold) | 4.88 | 4.01 | 2.04 | 6.07 | 2.20 | 1.09 | 3.38 | 3.81 | 3.43 |
| DIVA w/ EIG ‡ (Tuned on labels) | 0.38 | 0.23 | 0.12 | 1.43 | 0.73 | 0.46 | 1.43 | 1.49 | 0.78 |
| DIVA | 0.52 | 0.64 | 0.26 | 1.64 | 0.95 | 0.80 | 2.26 | 2.56 | 1.20 |
| DIVA-U | 0.41 | 0.51 | 0.20 | 1.08 | 0.64 | 0.77 | 0.78 | 0.73 | 0.64 |
| Held-out source | Selected ( , ) | DIVA (Point) | DIVA-U ( ) | DIVA-U (Selected) |
|---|---|---|---|---|
| Taiwan | (0.5, 1.0) | 0.53 | 0.44 | 0.32 |
| German | (0.5, 1.0) | 0.64 | 0.52 | 0.34 |
| CDC | (0.5, 1.0) | 0.81 | 0.70 | 0.40 |
| Heart | (0.5, 1.0) | 0.56 | 0.36 | 0.36 |
| SEC filings | (0.5, 1.0) | 0.53 | 0.26 | 0.24 |
| Family | Size | Prompting | Reference | Ablation | Ours | Verbal beliefs | ||||||
| Direct | Never | Always ask | DIVA w/ EIG | DIVA w/ EIG ‡ | DIVA w/ ES | DIVA w/ ES ‡ | DIVA (Elic.) | DIVA | Direct | DIVA | ||
| Qwen3 | 0.6B | 5.85 | 5.83 | 1.53 | 3.03 | 2.89 | 3.07 | 2.93 | 5.30 | 2.83 | 6.05 | 3.63 |
| 1.7B | 5.77 | 5.83 | 1.37 | 3.00 | 2.89 | 2.59 | 2.69 | 4.74 | 1.39 | 5.97 | 2.35 | |
| 4B | 3.36 | 5.83 | 1.14 | 2.89 | 2.28 | 2.04 | 1.86 | 3.27 | 0.22 | 3.76 | 1.11 | |
| 8B | 3.10 | 5.83 | 1.11 | 2.88 | 2.35 | 2.03 | 1.85 | 3.68 | 0.14 | 3.08 | 1.28 | |
| 14B | 2.86 | 5.83 | 1.10 | 2.88 | 2.37 | 2.02 | 1.85 | 4.43 | 0.13 | 2.58 | 0.90 | |
| Records | LLM policies ( 100, normalized by ) | Reference DP policy (Payoff points) | ||||||
| Never | DIVA | B / W | DIVA-U | B / W | Never | Ref. DP | Difference ( SE) | |
| Taiwan | 24.39 | 23.91 | 0 / 4 | 23.78 | 0 / 4 | 0.710 | 0.735 | 0.025 0.021 |
| German | 16.56 | 16.08 | 0 / 2 | 15.44 | 0 / 5 | 0.394 | 0.428 | 0.034 0.031 |
| CDC | 35.48 | 35.55 | 2 / 1 | 35.61 | 0 / 1 | 1.112 | 1.141 | 0.029 0.015 |
| Heart | 1.35 | 0.64 | 1 / 6 | 0.34 | 0 / 5 | 0.124 | 0.222 | 0.098 0.031 |
| Taiwan (5,000) | 25.18 | 24.80 | 0 / 6 | 24.56 | 0 / 8 | 25.94 † | 27.04 † | 1.10 0.25 † |
| Method (Avg. across 20 LLMs) | Credit | Clinical | SEC filings (2025–2026) | Avg. | |||||
|---|---|---|---|---|---|---|---|---|---|
| Taiwan | German | CDC | Heart | Ret-1d | Ret-5d | Vol-5d | Vol-20d | ||
| Prompting | |||||||||
| Direct | 6.68 | 5.43 | 5.26 | 7.25 | 2.12 | 1.79 | 1.84 | 1.73 | 4.01 |
| CoT ( Wei et al., 2022 ) | 7.72 | 6.98 | 6.62 | 7.98 | 1.94 | 1.76 | 2.08 | 2.12 | 4.65 |
| SC ( Wang et al., 2023 ) | 7.73 | 7.15 | 6.89 | 7.91 | 1.79 | 1.72 | 2.01 | 1.85 | 4.63 |
| ReAct ( Yao et al., 2023 ) | 9.13 | 7.76 | 8.12 | 8.48 | 2.48 | 2.22 | 2.28 | 2.45 | 5.37 |
| Selection | Knowledge-required | Controlled | ||||
|---|---|---|---|---|---|---|
| LLM | DIVA-U | DP | LLM | DIVA-U | DP | |
| LLM | 3.49 | 0.91 | 0.38 | 5.26 | 1.50 | 1.04 |
| EIG | 3.97 | 1.08 | 0.53 | 4.90 | 1.14 | 0.67 |
| DIVA-U | 2.23 | 0.65 | 0.25 | 2.90 | 0.86 | 0.28 |
| DP optimum | 1.92 | 0.38 | 0.00 | 2.55 | 0.64 | 0.00 |
| Method (Avg. across 20 LLMs) | Knowledge-required environments | Controlled environments | ||||||||||
| Credit | Clinical | SEC filings (2025–2026) | Finance | Credit | Clinical | Legal | ||||||
| Taiwan | German | CDC | Heart | Ret-1d | Ret-5d | Vol-5d | Vol-20d | |||||
| Prompting | ||||||||||||
| Direct | 6.47 | 5.15 | 5.23 | 6.30 | 1.26 | 1.21 | 1.24 | 1.08 | 4.69 | 4.35 | 6.22 | 5.80 |
| Direct + tuned stop | 3.43 | 2.68 | 2.50 | 4.30 | 1.81 | 1.35 | 2.33 | 2.59 | 4.39 | 4.39 | 5.49 | 5.57 |
| Salience | – | – | – | – | – | – | – | – | 5.48 | 4.51 | 6.87 | 6.71 |
| Decision model | Knowledge-required environments | Controlled environments | ||||||||||
| Credit | Clinical | SEC filings (2025–2026) | Finance | Credit | Clinical | Legal | ||||||
| Taiwan | German | CDC | Heart | Ret-1d | Ret-5d | Vol-5d | Vol-20d | |||||
| DIVA | 0.48 | 0.65 | 0.26 | 1.71 | 1.01 | 0.93 | 2.45 | 2.80 | ||||
| DIVA-U | 0.41 | 0.52 | 0.22 | 1.12 | 0.67 | 0.71 | 0.83 | 0.74 | 0.86 | 0.97 | 0.73 | 0.87 |
| DIVA, 25% | 0.52 | 0.70 | 0.31 | 1.78 | 1.23 | 1.06 | 2.55 | 3.02 | ||||
| DIVA-U, 25% | 0.42 | 0.56 | 0.24 | 1.24 | 0.68 | 0.71 | 0.85 | 0.75 | 1.00 | 0.99 | 0.86 | 0.97 |
| Policy | Credit | Clinical | SEC filings (2025–2026) | Avg. | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Taiwan | German | CDC | Heart | Ret-1d | Ret-5d | Vol-5d | Vol-20d | |||
| DIVA | 0.48 | 0.65 | 0.26 | 1.71 | 1.01 | 0.93 | 2.45 | 2.80 | 1.29 | |
| DIVA-U | 0.41 | 0.52 | 0.22 | 1.12 | 0.67 | 0.71 | 0.83 | 0.74 | 0.65 | |
| First decision | DIVA-PV | 0.46 | 0.64 | 0.26 | 1.71 | 1.02 | 0.94 | 2.57 | 2.99 | 1.32 |
| Never | 0.84 | 1.25 | 0.36 | 3.38 | 2.53 | 1.36 | 4.12 | 4.17 | 2.25 | |
| DIVA | 0.69 | 1.26 | 0.35 | 2.66 | 1.65 | 1.24 | 4.47 | 4.39 | 2.09 | |
| Env. | Direct | Never | Always ask | DIVA- | DIVA- | DIVA | DIVA-U | Stop DIVA-U | Uninformative (%, DIVA-U / Direct) |
|---|---|---|---|---|---|---|---|---|---|
| Ret-1d | 1.19 / 2.00 | 2.61 / 2.54 | 0.69 / 1.73 | 0.91 / 1.53 | 0.60 / 1.60 | 0.93 / 1.56 | 0.64 / 1.66 | 0.01 | 4.9 / 7.2 |
| Ret-5d | 1.17 / 1.47 | 0.99 / 0.90 | 0.87 / 1.32 | 0.72 / 0.91 | 0.66 / 1.04 | 0.79 / 0.99 | 0.79 / 1.20 | 0.02 | 4.7 / 7.2 |
| Vol-5d | 1.08 / 1.61 | 3.35 / 3.23 | 0.81 / 3.57 | 2.18 / 3.56 | 0.81 / 3.57 | 2.20 / 3.49 | 0.79 / 3.51 | 0.02 | 7.6 / 4.8 |
| Vol-20d | 1.05 / 1.61 | 3.78 / 3.69 | 0.77 / 3.95 | 2.43 / 4.02 | 0.76 / 3.92 | 2.48 / 3.88 | 0.72 / 3.72 | 0.03 | 9.9 / 3.9 |
| Policy | As built | Uniform | Far from belief | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ret-1d | Ret-5d | Vol-5d | Vol-20d | Ret-1d | Ret-5d | Vol-5d | Vol-20d | Ret-1d | Ret-5d | Vol-5d | Vol-20d | |
| Never | 2.64 | 1.76 | 3.71 | 4.38 | 0.56 | 0.46 | 1.07 | 1.64 | 0.10 | 0.01 | 0.38 | 0.52 |
| Always ask | 0.72 | 0.77 | 0.90 | 0.77 | 0.53 | 0.54 | 0.53 | 0.56 | 0.46 | 0.44 | 0.46 | 0.45 |
| Generic DIVA-U | 0.61 | 0.65 | 0.65 | 0.60 | 0.43 | 0.46 | 0.39 | 0.46 | 0.39 | 0.37 | 0.35 | 0.36 |
| DIVA | 1.01 | 0.93 | 2.45 | 2.80 | 0.30 | 0.29 | 0.78 | 1.13 | 0.14 | 0.08 | 0.37 | 0.52 |
| DIVA-DP | 0.86 | 0.77 | 2.02 | 2.37 | 0.29 | 0.26 | 0.69 | 0.96 | 0.15 | 0.11 | 0.32 | 0.46 |
| Env. | to never acquiring | DIVA-U wins | |||
|---|---|---|---|---|---|
| DIVA | DIVA-U | DIVA-DP † | All | Sig. | |
| Taiwan | 0.41 ∗ | 0.48 ∗ | 0.44 ∗ | 20/20 | 16/20 |
| German | 0.41 ∗ | 0.55 ∗ | 0.07 | 20/20 | 17/20 |
| CDC | 0.05 | 0.09 | 0.06 | 18/20 | 18/20 |
| Heart | 1.26 ∗ | 1.84 ∗ | 1.01 ∗ | 20/20 | 20/20 |
| Ret-1d | 1.64 ∗ | 1.97 ∗ | 1.21 ∗ | 16/20 | 15/20 |
| Method | Original | Para. 1 | Para. 2 | Spread |
|---|---|---|---|---|
| Direct | 5.26 | 5.31 | 5.18 | 0.39 |
| CoT ( Wei et al., 2022 ) | 5.16 | 5.21 | 5.14 | 0.41 |
| VoI-P | 5.00 | 4.97 | 4.99 | 0.56 |
| PAL ( Gao et al., 2023 ) | 4.39 | 4.29 | 4.62 | 0.44 |
| DIVA | 0.86 | 0.73 | 0.93 | 0.23 |
| DIVA-U (Records) | 0.57 | 0.58 | – | 0.06 |
| Family | Size | Direct | CoT | SC | ReAct | Ask-P | VoI-P | VoI-Ask | BED-LLM | PAL | Always ask | DIVA | DIVA-U | DIVA-DP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qwen3 | 0.6B | 0.89 | 1.29 | 0.94 | 10.38 | 1.42 | 0.91 | 0.70 | 0.89 | 1.80 | 5.56 | 0.90 | 0.67 | 0.82 |
| 1.7B | 4.97 | 6.91 | 6.40 | 10.34 | 4.34 | 4.36 | 0.77 | 10.07 | 6.91 | 5.51 | 0.67 | 0.57 | 0.60 | |
| 4B | 10.22 | 10.46 | 10.37 | 10.50 | 10.77 | 11.28 | 0.70 | 4.45 | 2.73 | 5.15 | 0.34 | 0.33 | 0.32 | |
| 8B | 6.56 | 8.79 | 9.75 | 8.90 | 3.18 | 9.16 | 0.71 | 5.10 | 2.86 | 5.23 | 0.48 | 0.43 | 0.37 | |
| 14B | 6.33 | 7.68 | 7.28 | 8.71 | 9.55 | 6.54 | 0.77 | 8.30 | 2.24 | 5.00 | 0.31 | 0.32 | 0.26 | |
| 32B | 3.63 | 6.01 | 5.84 | 5.89 | 8.42 | 3.57 | 0.80 | 7.27 | 2.11 | 5.34 | 0.67 | 0.68 | 0.57 |
| Family | Size | Direct | CoT | SC | ReAct | Ask-P | VoI-P | VoI-Ask | BED-LLM | PAL | Always ask | DIVA | DIVA-U | DIVA-DP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qwen3 | 0.6B | 1.06 | 1.13 | 1.19 | 7.95 | 1.06 | 1.11 | 1.05 | 1.45 | 1.39 | 4.77 | 1.09 | 0.99 | 0.95 |
| 1.7B | 2.46 | 5.29 | 5.29 | 8.03 | 2.18 | 4.03 | 2.02 | 8.32 | 4.06 | 4.41 | 0.61 | 0.49 | 0.44 | |
| 4B | 8.92 | 8.93 | 9.67 | 8.16 | 10.05 | 10.77 | 1.06 | 2.47 | 3.42 | 4.69 | 0.85 | 0.87 | 0.79 | |
| 8B | 3.76 | 8.25 | 8.45 | 8.51 | 2.41 | 10.06 | 1.06 | 5.38 | 2.34 | 4.44 | 0.68 | 0.46 | 0.51 | |
| 14B | 4.74 | 6.97 | 6.94 | 7.73 | 9.83 | 4.56 | 1.06 | 7.95 | 1.70 | 4.47 | 0.54 | 0.42 | 0.37 | |
| 32B | 2.83 | 5.12 | 4.86 | 5.13 | 8.08 | 4.61 | 1.06 | 6.30 | 1.29 | 4.61 | 0.78 | 0.70 | 0.69 |
| Family | Size | Direct | CoT | SC | ReAct | Ask-P | VoI-P | VoI-Ask | BED-LLM | PAL | Always ask | DIVA | DIVA-U | DIVA-DP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qwen3 | 0.6B | 0.31 | 1.31 | 1.00 | 9.26 | 0.31 | 1.00 | 1.87 | 0.31 | 1.49 | 5.38 | 1.41 | 1.64 | 1.68 |
| 1.7B | 2.88 | 5.80 | 6.23 | 8.95 | 0.46 | 4.81 | 0.45 | 7.76 | 2.12 | 4.82 | 0.24 | 0.22 | 0.25 | |
| 4B | 9.19 | 8.58 | 9.20 | 8.70 | 9.16 | 9.91 | 0.31 | 0.31 | 2.78 | 4.75 | 0.16 | 0.19 | 0.16 | |
| 8B | 4.84 | 8.75 | 8.48 | 9.03 | 4.00 | 6.50 | 0.72 | 0.31 | 1.43 | 4.81 | 0.24 | 0.14 | 0.21 | |
| 14B | 6.17 | 7.58 | 7.59 | 7.96 | 8.21 | 3.81 | 1.28 | 0.38 | 1.05 | 4.73 | 0.11 | 0.08 | 0.07 | |
| 32B | 1.91 | 6.73 | 6.88 | 6.26 | 8.31 | 4.96 | 1.36 | 0.31 | 0.84 | 4.68 | 0.11 | 0.08 | 0.06 |
| Family | Size | Direct | CoT | SC | ReAct | Ask-P | VoI-P | VoI-Ask | BED-LLM | PAL | Always ask | DIVA | DIVA-U | DIVA-DP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qwen3 | 0.6B | 2.96 | 4.13 | 3.55 | 8.33 | 2.96 | 3.28 | 2.97 | 2.98 | 4.21 | 4.45 | 2.21 | 1.45 | 1.94 |
| 1.7B | 4.01 | 8.15 | 8.67 | 8.33 | 7.02 | 5.74 | 2.96 | 7.63 | 5.38 | 3.96 | 2.22 | 1.14 | 2.03 | |
| 4B | 8.66 | 8.46 | 8.20 | 7.65 | 10.24 | 9.26 | 2.98 | 5.34 | 3.71 | 4.05 | 1.59 | 1.06 | 1.27 | |
| 8B | 7.64 | 8.02 | 7.76 | 8.35 | 5.95 | 8.90 | 2.76 | 7.20 | 3.20 | 4.50 | 1.80 | 1.32 | 1.52 | |
| 14B | 6.87 | 7.68 | 7.57 | 8.11 | 9.14 | 7.08 | 3.13 | 7.37 | 4.54 | 4.06 | 1.72 | 1.05 | 1.35 | |
| 32B | 4.00 | 5.54 | 4.78 | 5.90 | 7.25 | 5.33 | 2.75 | 7.09 | 3.34 | 3.98 | 1.54 | 1.04 | 1.36 |
| Family | Size | Direct | CoT | SC | ReAct | Ask-P | VoI-P | VoI-Ask | BED-LLM | PAL | Always ask | DIVA | DIVA-U | DIVA-DP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qwen3 | 0.6B | 2.64 | 2.37 | 2.42 | 1.53 | 2.63 | 2.54 | 1.96 | 0.84 | 2.52 | 0.71 | 2.42 | 0.74 | 2.35 |
| 1.7B | 2.22 | 1.76 | 1.76 | 1.55 | 2.64 | 2.25 | 2.29 | 1.36 | 2.38 | 1.22 | 1.61 | 1.11 | 1.41 | |
| 4B | 0.71 | 1.03 | 1.07 | 1.24 | 1.15 | 2.45 | 2.64 | 1.47 | 2.16 | 0.98 | 1.04 | 0.91 | 0.99 | |
| 8B | 0.82 | 1.08 | 0.93 | 1.07 | 1.73 | 2.51 | 1.41 | 1.58 | 2.27 | 0.67 | 0.70 | 0.61 | 0.55 | |
| 14B | 0.81 | 0.83 | 0.75 | 0.81 | 0.82 | 2.02 | 1.94 | 1.19 | 1.73 | 0.59 | 0.68 | 0.52 | 0.55 | |
| 32B | 1.32 | 0.61 | 0.59 | 0.84 | 0.91 | 0.82 | 1.94 | 1.22 | 1.53 | 0.66 | 0.59 | 0.60 | 0.58 |
| Family | Size | Direct | CoT | SC | ReAct | Ask-P | VoI-P | VoI-Ask | BED-LLM | PAL | Always ask | DIVA | DIVA-U | DIVA-DP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qwen3 | 0.6B | 1.76 | 1.70 | 1.70 | 1.60 | 1.69 | 1.74 | 1.56 | 0.76 | 1.65 | 0.73 | 1.67 | 0.68 | 1.57 |
| 1.7B | 1.72 | 1.65 | 1.69 | 1.72 | 1.81 | 1.89 | 1.24 | 1.53 | 1.72 | 1.03 | 1.51 | 1.00 | 1.38 | |
| 4B | 0.82 | 1.33 | 1.22 | 1.49 | 1.29 | 1.60 | 1.70 | 1.63 | 1.69 | 0.99 | 1.07 | 0.91 | 0.86 | |
| 8B | 0.92 | 1.16 | 1.14 | 1.22 | 1.47 | 1.93 | 1.07 | 1.49 | 1.72 | 0.77 | 0.72 | 0.71 | 0.61 | |
| 14B | 0.82 | 1.04 | 0.96 | 1.11 | 0.98 | 1.79 | 1.52 | 1.29 | 1.57 | 0.65 | 0.67 | 0.63 | 0.58 | |
| 32B | 1.05 | 0.82 | 0.79 | 0.94 | 1.06 | 1.05 | 1.33 | 1.31 | 1.34 | 0.73 | 0.61 | 0.69 | 0.57 |
| Family | Size | Direct | CoT | SC | ReAct | Ask-P | VoI-P | VoI-Ask | BED-LLM | PAL | Always ask | DIVA | DIVA-U | DIVA-DP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qwen3 | 0.6B | 3.71 | 2.83 | 3.32 | 1.50 | 3.59 | 3.71 | 1.79 | 3.71 | 3.40 | 0.75 | 3.49 | 0.82 | 3.44 |
| 1.7B | 1.11 | 1.21 | 1.06 | 1.06 | 3.64 | 2.69 | 3.42 | 1.65 | 3.41 | 1.00 | 2.76 | 1.02 | 2.67 | |
| 4B | 1.29 | 1.17 | 1.11 | 1.06 | 1.22 | 1.76 | 3.31 | 1.60 | 2.89 | 0.86 | 2.41 | 0.79 | 2.03 | |
| 8B | 0.93 | 1.08 | 0.99 | 1.01 | 1.73 | 2.40 | 2.64 | 1.69 | 3.09 | 0.78 | 3.01 | 0.76 | 2.54 | |
| 14B | 1.54 | 0.94 | 1.02 | 0.94 | 1.28 | 3.76 | 3.44 | 1.65 | 2.60 | 0.90 | 2.44 | 0.84 | 1.88 | |
| 32B | 2.05 | 0.91 | 0.98 | 0.90 | 1.10 | 1.17 | 3.26 | 1.64 | 2.47 | 0.98 | 2.08 | 0.92 | 1.65 |
| Family | Size | Direct | CoT | SC | ReAct | Ask-P | VoI-P | VoI-Ask | BED-LLM | PAL | Always ask | DIVA | DIVA-U | DIVA-DP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qwen3 | 0.6B | 4.38 | 3.49 | 3.84 | 1.17 | 4.30 | 4.38 | 2.41 | 4.38 | 4.16 | 0.80 | 4.06 | 0.81 | 4.05 |
| 1.7B | 0.99 | 1.05 | 0.75 | 0.86 | 3.84 | 2.68 | 4.25 | 1.55 | 3.75 | 1.03 | 3.23 | 0.98 | 3.12 | |
| 4B | 0.85 | 0.78 | 0.74 | 0.79 | 1.01 | 1.91 | 4.13 | 1.56 | 3.02 | 0.76 | 2.62 | 0.70 | 2.31 | |
| 8B | 0.62 | 0.80 | 0.69 | 0.68 | 1.63 | 3.00 | 3.12 | 1.52 | 3.88 | 0.68 | 3.27 | 0.63 | 2.55 | |
| 14B | 1.34 | 0.67 | 0.65 | 0.79 | 0.80 | 3.98 | 4.24 | 1.42 | 3.15 | 0.69 | 2.89 | 0.82 | 2.30 | |
| 32B | 1.92 | 0.70 | 0.73 | 0.94 | 0.86 | 0.95 | 4.24 | 1.55 | 2.56 | 0.85 | 2.29 | 0.79 | 1.92 |
| Family | Size | Direct | CoT | SC | ReAct | Reason. | Ask-P | VoI-P | VoI-Ask | BED-LLM | PAL | Always ask | DIVA | DIVA-DP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qwen3 | 0.6B | 4.67 | 5.77 | 5.55 | 6.42 | 5.98 | 4.40 | 4.74 | 4.33 | 4.67 | 4.80 | 3.15 | 2.77 | 2.51 |
| 1.7B | 5.99 | 6.36 | 6.06 | 6.58 | 5.86 | 7.08 | 4.39 | 4.39 | 5.25 | 5.03 | 2.92 | 1.46 | 0.97 | |
| 4B | 6.00 | 5.52 | 5.50 | 5.64 | 3.65 | 6.04 | 6.22 | 4.24 | 5.39 | 4.49 | 2.58 | 0.86 | 0.52 | |
| 8B | 5.76 | 5.37 | 5.29 | 5.72 | 3.02 | 5.64 | 6.28 | 3.90 | 5.45 | 4.72 | 2.45 | 0.66 | 0.33 | |
| 14B | 5.57 | 5.35 | 4.98 | 5.16 | 2.24 | 5.53 | 5.28 | 4.11 | 6.57 | 4.08 | 2.44 | 0.57 | 0.29 | |
| 32B | 4.48 | 3.97 | 4.08 | 3.74 | 1.04 | 5.06 | 3.69 | 4.08 | 6.40 | 4.35 | 2.47 | 0.60 | 0.27 |
| Family | Size | Direct | CoT | SC | ReAct | Reason. | Ask-P | VoI-P | VoI-Ask | BED-LLM | PAL | Always ask | DIVA | DIVA-DP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qwen3 | 0.6B | 4.63 | 5.99 | 5.14 | 6.71 | 6.02 | 4.63 | 4.80 | 4.60 | 4.63 | 5.00 | 3.08 | 3.36 | 3.29 |
| 1.7B | 5.36 | 5.81 | 5.41 | 6.73 | 5.25 | 7.49 | 4.27 | 4.60 | 5.23 | 5.49 | 2.92 | 1.53 | 1.08 | |
| 4B | 5.59 | 5.12 | 5.27 | 5.54 | 3.03 | 6.02 | 5.92 | 4.54 | 5.50 | 4.76 | 2.41 | 0.85 | 0.54 | |
| 8B | 5.22 | 4.47 | 4.90 | 5.33 | 2.68 | 4.98 | 5.47 | 4.60 | 5.21 | 4.13 | 2.30 | 0.80 | 0.51 | |
| 14B | 4.50 | 5.25 | 4.89 | 4.72 | 2.45 | 4.45 | 4.88 | 4.50 | 5.92 | 4.38 | 2.18 | 0.61 | 0.41 | |
| 32B | 3.57 | 3.82 | 3.63 | 3.58 | 0.84 | 4.26 | 4.06 | 4.47 | 5.99 | 4.10 | 2.21 | 0.41 | 0.24 |
| Family | Size | Direct | CoT | SC | ReAct | Reason. | Ask-P | VoI-P | VoI-Ask | BED-LLM | PAL | Always ask | DIVA | DIVA-DP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qwen3 | 0.6B | 4.54 | 4.84 | 4.93 | 5.21 | 5.43 | 3.48 | 4.39 | 3.58 | 4.54 | 4.46 | 2.48 | 2.92 | 2.65 |
| 1.7B | 4.93 | 5.24 | 5.92 | 5.04 | 4.97 | 5.95 | 4.50 | 4.24 | 4.64 | 4.53 | 2.33 | 1.80 | 1.24 | |
| 4B | 4.95 | 4.29 | 4.22 | 4.58 | 3.43 | 4.90 | 4.89 | 4.24 | 4.10 | 3.82 | 1.88 | 0.90 | 0.57 | |
| 8B | 4.64 | 4.56 | 3.98 | 4.47 | 2.66 | 4.62 | 4.66 | 3.88 | 4.81 | 3.84 | 1.76 | 0.69 | 0.31 | |
| 14B | 4.33 | 3.92 | 4.10 | 4.23 | 2.13 | 4.38 | 4.47 | 3.97 | 5.45 | 3.71 | 1.88 | 0.75 | 0.32 | |
| 32B | 3.52 | 3.72 | 3.49 | 2.66 | 0.96 | 3.98 | 3.12 | 4.35 | 5.21 | 4.35 | 1.95 | 0.91 | 0.35 |
| Family | Size | Direct | CoT | SC | ReAct | Reason. | Ask-P | VoI-P | VoI-Ask | BED-LLM | PAL | Always ask | DIVA | DIVA-DP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qwen3 | 0.6B | 4.52 | 7.01 | 6.63 | 6.51 | 6.00 | 4.52 | 4.77 | 4.27 | 4.52 | 4.72 | 3.48 | 1.74 | 1.25 |
| 1.7B | 6.84 | 6.84 | 6.89 | 7.10 | 6.39 | 9.01 | 3.80 | 4.13 | 6.56 | 4.82 | 3.38 | 1.13 | 0.71 | |
| 4B | 7.19 | 5.73 | 6.02 | 6.33 | 2.77 | 7.22 | 7.11 | 4.15 | 6.95 | 4.71 | 3.21 | 0.94 | 0.53 | |
| 8B | 6.54 | 5.75 | 5.70 | 6.30 | 2.92 | 5.22 | 7.28 | 2.65 | 6.63 | 4.82 | 2.90 | 0.58 | 0.20 | |
| 14B | 6.93 | 6.22 | 5.48 | 6.11 | 1.83 | 6.87 | 5.46 | 3.25 | 8.03 | 3.75 | 2.98 | 0.45 | 0.22 | |
| 32B | 6.07 | 4.27 | 5.07 | 4.16 | 0.78 | 6.01 | 3.74 | 2.89 | 7.45 | 3.57 | 3.02 | 0.57 | 0.26 |
| Family | Size | Direct | CoT | SC | ReAct | Reason. | Ask-P | VoI-P | VoI-Ask | BED-LLM | PAL | Always ask | DIVA | DIVA-DP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qwen3 | 0.6B | 4.98 | 5.22 | 5.51 | 7.25 | 6.48 | 4.98 | 5.00 | 4.87 | 4.98 | 5.01 | 3.56 | 3.05 | 2.86 |
| 1.7B | 6.83 | 7.55 | 6.03 | 7.45 | 6.82 | 5.86 | 4.99 | 4.58 | 4.59 | 5.26 | 3.04 | 1.38 | 0.84 | |
| 4B | 6.28 | 6.91 | 6.50 | 6.11 | 5.35 | 6.04 | 6.94 | 4.03 | 5.03 | 4.69 | 2.82 | 0.75 | 0.43 | |
| 8B | 6.65 | 6.68 | 6.58 | 6.80 | 3.83 | 7.72 | 7.73 | 4.46 | 5.15 | 6.10 | 2.83 | 0.58 | 0.30 | |
| 14B | 6.52 | 6.03 | 5.46 | 5.57 | 2.54 | 6.43 | 6.31 | 4.71 | 6.88 | 4.47 | 2.72 | 0.47 | 0.22 | |
| 32B | 4.76 | 4.09 | 4.15 | 4.54 | 1.59 | 5.97 | 3.85 | 4.63 | 6.96 | 5.38 | 2.70 | 0.49 | 0.25 |
| Family | Size | Direct | CoT | SC | ReAct | Ask-P | VoI-P | VoI-Ask | BED-LLM | PAL | Never | Always ask | DIVA | DIVA-DP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qwen3 | 0.6B | 15.43 | 18.20 | 16.94 | 38.96 | 15.52 | 16.65 | 15.43 | 15.43 | 15.91 | 15.40 | 40.41 | 5.62 | 5.46 |
| 1.7B | 19.28 | 25.68 | 29.61 | 36.04 | 23.52 | 15.34 | 14.78 | 17.43 | 17.41 | 14.46 | 41.55 | 5.17 | 5.13 | |
| 4B | 34.52 | 31.76 | 34.15 | 29.84 | 26.07 | 30.88 | 12.02 | 14.41 | 13.22 | 11.66 | 35.67 | 1.64 | 1.44 | |
| 8B | 32.44 | 27.49 | 30.07 | 28.77 | 18.39 | 31.25 | 11.96 | 13.22 | 13.03 | 11.53 | 35.12 | 1.19 | 0.88 | |
| 14B | 31.05 | 29.44 | 30.95 | 27.13 | 33.44 | 13.18 | 10.44 | 27.25 | 12.05 | 10.38 | 35.43 | 0.92 | 0.70 | |
| 32B | 19.55 | 24.78 | 27.48 | 22.82 | 32.34 | 7.44 | 6.99 | 27.28 | 6.94 | 6.17 | 35.91 | 0.96 | 0.62 |
LLM Decision-Making
LLM decision-making studies how language models choose, act, seek information, and allocate resources under goals, uncertainty, constraints, and social pressures.
See all 242 papers